- Home
- ATGL vs ABEO Comparison
ATGL vs ABEO Comparison
Compare ATGL & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ATGL | ABEO |
|---|---|---|
| Founded | 2017 | 1974 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 232.1M | 307.5M |
| IPO Year | 2023 | 2005 |
Fundamental Metrics
Financial Performance| Metric | ATGL | ABEO |
|---|---|---|
| Price | $13.50 | $5.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 947.0 | ★ 942.3K |
| Earning Date | 01-27-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.16 |
| EPS | N/A | ★ 1.01 |
| Revenue | N/A | ★ $2,998,000.00 |
| Revenue This Year | N/A | $1,024.31 |
| Revenue Next Year | N/A | $145.42 |
| P/E Ratio | ★ N/A | $5.23 |
| Revenue Growth | N/A | ★ 258.18 |
| 52 Week Low | $9.01 | $4.00 |
| 52 Week High | $50.00 | $7.54 |
Technical Indicators
Market Signals| Indicator | ATGL | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 35.46 | 60.55 |
| Support Level | $9.01 | $5.24 |
| Resistance Level | $20.25 | $5.64 |
| Average True Range (ATR) | 0.56 | 0.20 |
| MACD | -0.14 | 0.00 |
| Stochastic Oscillator | 20.23 | 68.03 |
Price Performance
Historical ComparisonAbout ATGL Alpha Technology Group Limited
Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.